FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-115600.
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
fj.08-115600v1
23/1/134    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klein, J.
Right arrow Articles by Bascands, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klein, J.
Right arrow Articles by Bascands, J. L.
(The FASEB Journal. 2009;23:134-142.)
© 2009 FASEB

Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy

J. Klein*,{dagger},1, J. Gonzalez*,{dagger},1, J. Duchene*,{ddagger}, L. Esposito§, J. P. Pradère*,{dagger}, E. Neau*,{dagger}, C. Delage*,{dagger}, D. Calise||, A. Ahluwalia{ddagger}, P. Carayon, J. B. Pesquero#, M. Bader**, J. P. Schanstra*,{dagger},2 and J. L. Bascands*,{dagger},2

* INSERM, Department of Renal and Cardiac Remodeling–Team 5, Toulouse, France;

{dagger} Université Toulouse III Paul Sabatier, Toulouse, France;

{ddagger} William Harvey Research Institute, Barts, and the London Medical School, London, UK;

§ Nephrology and Kidney Transplantation Department, CHU Rangueil, Toulouse University Hospital, Toulouse, France;

|| INSERM, Zootechny Department of Experimental Micro-Surgery, Toulouse, France;

Sanofi-Aventis R&D, Montpellier, France;

# Department of Biophysics, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil; and

** Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany

2 Correspondence: INSERM, Department of Renal and Cardiac Remodeling–Team 5, 1 av Jean-Poulhes, 31432 Toulouse, France. E-mail: J.L.B., jean-loup.bascands{at}inserm.fr; J.P.S., joost-peter.schanstra{at}inserm.fr

Renal fibrosis is the common histological feature of advanced glomerular and tubulointerstitial disease leading to end-stage renal disease (ESRD). However, specific antifibrotic therapies to slow down the evolution to ESRD are still absent. Because persistent inflammation is a key event in the development of fibrosis, we hypothesized that the proinflammatory kinin B1 receptor (B1R) could be such a new target. Here we show that, in the unilateral ureteral obstruction model of renal fibrosis, the B1R is overexpressed and that delayed treatment with an orally active nonpeptide B1R antagonist blocks macrophage infiltration, leading to a reversal of the level of renal fibrosis. In vivo bone marrow transplantation studies as well as in vitro studies on renal cells show that part of this antifibrotic mechanism of B1R blockade involves a direct effect on resident renal cells by inhibiting chemokine CCL2 and CCL7 expression. These findings suggest that blocking the B1R is a promising antifibrotic therapy.—Klein, J., Gonzalez, J., Duchene, J., Esposito, L., Pradère, J. P., Neau, E., Delage, C., Calise, D., Ahluwalia, A., Carayon, P., Pesquero, J. B., Bader, M., Schanstra, J. P., Bascands, J. L. Delayed blockade of the kinin B1 receptor reduces renal inflammation and fibrosis in obstructive nephropathy.


Key Words: kidney disease • bradykinin • unilateral ureteral obstruction • chemokine • reversion




This article has been cited by other articles:


Home page
Exp Biol MedHome page
J. Gonzalez, J. Klein, S. D. Chauhan, E. Neau, D. Calise, C. Nevoit, R. Chaaya, M. Miravete, C. Delage, J.-L. Bascands, et al.
Delayed Treatment with Plasminogen Activator Inhibitor-1 Decoys Reduces Tubulointerstitial Fibrosis
Exp Biol Med, December 1, 2009; 234(12): 1511 - 1518.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Westermann, T. Walther, K. Savvatis, F. Escher, M. Sobirey, A. Riad, M. Bader, H.-P. Schultheiss, and C. Tschope
Gene Deletion of the Kinin Receptor B1 Attenuates Cardiac Inflammation and Fibrosis During the Development of Experimental Diabetic Cardiomyopathy
Diabetes, June 1, 2009; 58(6): 1373 - 1381.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.